Page not found

Search results

  1. Vanderbilt inks collaboration with Neumora Therapeutics, Inc to continue development of investigational treatment for neuropsychiatric disorders

    ... in the labs of Warren Center for Neuroscience Drug Discovery Director  Craig Lindsley   and Director Emeritus  P. Jeffrey ... Thomas Utley, senior licensing officer at the  Center for Technology Transfer and Commercialization . “The team that Neumora has put ...

    sommers - 05/06/2022 - 10:50am

  2. Jeff Conn named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics

    ... Society for Pharmacology and Experimental Therapeutics . Selection as a fellow of ASPET is an honor bestowed on members who have ... director of the  Warren Center for Neuroscience Drug Discovery . “I joined ASPET as a young graduate student here at Vanderbilt ...

    sommers - 10/07/2021 - 8:29am

  3. Ancora announces major funding awards to support Vanderbilt drug discovery research

    ... chemistry at the  Vanderbilt Center for Neuroscience Drug Discovery , and  Jeffery Conn , Lee E. Limbird professor of pharmacology in ... of the Vice Provost for Research  and the  Center for Technology Transfer and Commercialization  will be assisting faculty ...

    sommers - 02/21/2019 - 9:51am

  4. Vanderbilt-discovered drug candidate for Parkinson’s disease enters clinical trials

    ... developed at the  Warren Center for Neuroscience Drug Discovery  have been initiated by  Appello Pharmaceuticals Inc ., a ... to use the findings from the Phase 1 study to inform dose selection for its Phase 1b and Phase 2 clinical studies in people with ...

    sommers - 10/07/2021 - 8:52am

  5. Tech Connect, Vol. 7, Issue 3: CTTC launches Startup Vanderbilt's Pre-Flight Program

    ... Vanderbilt” initiative, the Vanderbilt Center for Technology Transfer and Commercialization and the Vanderbilt Innovation Center, ... Research in the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) aimed at developing innovative new treatments for ...

    steelmk - 11/10/2016 - 7:45am

  6. Discovery of natural compound may help fend off antibiotic resistance of hard-to-treat infections

    ... in the U.S. each year. The article announcing this discovery, “A bifunctional nitrone conjugated secondary metabolite targeting ...  bacteria. Bachmann is working with the  Center for Technology Transfer and Commercialization  to explore development for ...

    sommers - 08/19/2020 - 6:47pm

  7. Flu’s “hidden target” may lead to universal vaccine: study

    ... and H3N2 mutate continuously, vaccines sometimes provide variable or incomplete protection and must be updated annually. Poor matches ... often able to evade immune detection. That’s why the discovery by VUMC and Scripps researchers of a broadly protective, naturally ...

    sommers - 05/20/2019 - 1:02pm

  8. Faculty can quickly and easily share their innovative ideas using CTTC’s new online tool

    02/15/2024 The Center for Technology Transfer and Commercialization has introduced a new tool that makes ...

    sommers - 02/15/2024 - 1:35pm

  9. Tech Connect, Vol. 6, Issue 21: Current cancer drug discovery method flawed says VUMC study

    ... Current cancer drug discovery method flawed: VUMC study The primary method used to ... tools and c areer and training opportunities in Technology Transfer.   The Symposium was sponsored by  The ...

    steelmk - 11/10/2016 - 7:45am

  10. Innovation Catalyst Fund announces eight inaugural awardees; next round submission deadline is April 15

    ... Cybele Raver and Vice Chancellor for Finance and Information Technology Brett Sweet, received 24 submissions and will provide pre-seed ... to be refined for potential resubmission. The Center for Technology Transfer and Commercialization manages the proposal submission and ...

    sommers - 02/13/2024 - 10:43am